Predicting Osteoradionecrosis Risk in Nasopharyngeal Cancer Patients
Author Information
Author(s): Durankus Nulifer Kilic, Somay Efsun, Bascil Sibel, Senyurek Sukran, Ozturk Duriye, Selek Ugur, Topkan Erkan
Primary Institution: Koc University, Istanbul, Türkiye
Hypothesis
Can the CARWL index predict the risk of osteoradionecrosis in patients with locoregionally advanced nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy?
Conclusion
The CARWL index is a reliable predictive tool for evaluating the risk of osteoradionecrosis in patients with locoregionally advanced nasopharyngeal cancer undergoing concurrent chemoradiotherapy.
Supporting Evidence
- 28 patients (9.2%) developed osteoradionecrosis at a median follow-up of 67.2 months.
- The incidence of osteoradionecrosis was 2.1%, 9.4%, and 16.3% in the CARWL-0, CARWL-1, and CARWL-2 groups, respectively.
- Multivariate analysis identified smoking status, N-stage, T-stage, and tooth extraction status as significant predictors of osteoradionecrosis.
Takeaway
Doctors can use the CARWL index to figure out which nasopharyngeal cancer patients are more likely to have problems with their jaw after treatment, helping them take better care of those patients.
Methodology
A retrospective cohort analysis was conducted on 304 patients with locoregionally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy, categorizing them into CARWL index groups based on C-reactive protein-to-albumin ratio and significant weight loss.
Potential Biases
Potential selection bias due to the retrospective nature of the study.
Limitations
The study's single-center retrospective design may introduce selection bias, and the analysis was based on a single set of CARWL data before treatment.
Participant Demographics
Median age was 55 years, with a male predominance of 67.8%.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website